Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Altimmune, Inc.    ALT

ALTIMMUNE, INC.

(ALT)
  Report  
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 2017 2018 2019 (e) 2020 (e) 2021 (e)
Sales 10,7 10,3 9,79 10,3 -
EBITDA - - - - -
Operating profit (EBIT) -52,0 - -11,3 -11,5 -
Pre-Tax Profit (EBT) - - -10,6 -10,6 -
Net income - - -11,1 -12,5 -
P/E ratio - - -2,30x -2,36x -
EPS (  ) - - -0,89 -0,87 -
Dividend per Share (  ) - - - - -
Yield - - - - -
Reference price ( $ ) 59,700 2,060 2,050 2,050 2,050
Announcement Date 03/28/2018
08:44pm
04/01/2019
08:19pm
- - -
Finances - Leverage
Estimates in  $
Fiscal Period December 2019 (e) 2020 (e) 2021 (e)
Debt - - -
Finance 0,00 0,00 0,00
Operating income (EBITDA) - - -
Leverage
(Debt/EBITDA)
- - -
Capital Expenditure - - -
Free Cash Flow (FCF) - - -
Book Value Per Share (BVPS) (  ) - - -
Cash Flow per Share (  ) - - -
Announcement Date - - -
Balance Sheet Analysis
Assessed data source
© 2019 S&P Global Market Intelligence
Financial Ratios

Size 2019e 2020e
Capitalization 31 M $ -
Valuation 2019e 2020e
P/E ratio (Price / EPS) -2,30x -2,36x
Capitalization / Revenue 3,14x 2,99x
Yield (DPS / Price) - -
Price to book (Price / BVPS) - -
Profitability 2019e 2020e
Operating Margin (EBIT / Sales) -116% -111%
Operating Leverage (Delta EBIT / Delta Sales) - -
Net Margin (Net Profit / Revenue) -113% -121%
ROA (Net Profit / Asset) - -
ROE (Net Profit / Equities) - -
Rate of Dividend - -
Balance Sheet Analysis 2019e 2020e
CAPEX / Sales   0 0
Cash Flow / Sales - -
Capital Intensity (Assets / Sales) - -
Financial Leverage (Net Debt / EBITDA) - -
EPS & Dividend